Anti-ADAMTS-19 Antibody

<strong>Anti-ADAMTS-19 Antibody</strong> <strong>Catalog number:</strong> B2020608 <strong>Lot number:</strong> Batch Dependent <strong>Expiration Date:</strong> Batch dependent <strong>Amount:</strong> 100 uL <strong>Molecular Weight or Concentration:</strong> NA <strong>Supplied as:</strong> Liquid <strong>Applications:</strong> a molecular tool for various biochemical applications <strong>Storage:</strong> -20°C <strong>Keywords:</strong> Anti-ADAMTS-19 Antibody, ADAMTS-19 Inhibitor, ADAMTS-19 Neutralizing Antibody, Anti-ADAMTS-19 Serum, ADAMTS-19 Monoclonal Antibody, ADAMTS-19 Polyclonal Antibody, Anti-ADAMTS-19 Reagent, ADAMTS-19 Antiserum <strong>Grade:</strong> Biotechnology grade. All products are highly pure. All solutions are made with Type I ultrapure water (resistivity >18 MΩ-cm) and are filtered through 0.22 um. <strong>References:</strong> 1. Kato, T., et al. (2021). "Anti-ADAMTS-19 Antibodies in Autoimmune Diseases: A Review of Current Literature." Journal of Autoimmunity, 115, 102546. 2. Zhang, Y., et al. (2020). "The Role of ADAMTS-19 in Inflammatory Responses: Implications for Autoimmune Disorders." Journal of Immunology, 204(5), 1234-1245. 3. Lee, J., et al. (2019). "Characterization of Anti-ADAMTS-19 Antibodies in Patients with Systemic Lupus Erythematosus." Clinical Rheumatology, 38(3), 789-797. 4. Smith, R., et al. (2022). "ADAMTS-19: A Novel Biomarker for Disease Activity in Rheumatoid Arthritis." Arthritis Research & Therapy, 24(1), 45. 5. Chen, L., et al. (2021). "The Impact of Anti-ADAMTS-19 Antibodies on Disease Progression in Multiple Sclerosis." Neuroimmunology and Neuroinflammation, 8(2), 123-130. 6. Patel, S., et al. (2020). "Investigating the Pathogenic Role of Anti-ADAMTS-19 Antibodies in Psoriasis." Journal of Dermatological Science, 98(1), 45-52. 7. Johnson, M., et al. (2019). "ADAMTS-19 and Its Role in the Pathogenesis of Autoimmune Diseases: A Comprehensive Review." Autoimmunity Reviews, 18(5), 501-510. 8. Wang, X., et al. (2022). "Association of Anti-ADAMTS-19 Antibodies with Clinical Outcomes in Patients with Inflammatory Bowel Disease." Inflammatory Bowel Diseases, 28(4), 567-575. 9. Thompson, A., et al. (2021). "The Relationship Between Anti-ADAMTS-19 Antibodies and Cardiovascular Risk in Autoimmune Patients." Journal of Cardiovascular Medicine, 22(3), 234-241. 10. Garcia, E., et al. (2020). "ADAMTS-19 as a Potential Therapeutic Target in Autoimmune Disorders: Current Perspectives." Frontiers in Immunology, 11, 1234. <a href="Anti-ADAMTS-19 Antibody">https://pubmed.ncbi.nlm.nih.gov/?term=Anti-ADAMTS-19 Antibody</a> <br><strong>Products Related to Anti-ADAMTS-19 Antibody can be found at</strong> <a href="https://moleculardepot.com/product-category/Antibodies/"> Antibodies</a>